Acetylcysteine (Mucoloc, Corenza Muco, Acetylcysteine Adco)
Acetylcysteine
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Registrations
- 5
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Mucoloc EACH TABLET CONTAINS ACETYLCYSTEINE 600,0 mg | Not listed | 57036257/10.3/0362 | Registered | Not determined | None |
| Corenza muco 200 EACH TABLET CONTAINS: ACETYLCYSTEINE 200,0 mg | 200Effervescent tablet. | 57086357/10.3/0863Approved 18 September 2025 | Registered | S1 | PIPIL |
| Corenza muco 600 EACH TABLET CONTAINS: ACETYLCYSTEINE 600,0 mg | 600Effervescent tablet. | 57086457/10.3/0864Approved 18 September 2025 | Registered | S1 | PIPIL |
| Acetylcysteine 200 adco EACH TABLET CONTAINS: ACETYLCYSTEINE 200,0 mg | 200Effervescent tablet. | 570865.86357/10.3/0865.863Approved 18 September 2025 | Registered | S1 | PIPIL |
| Acetylcysteine 600 adco EACH TABLET CONTAINS: ACETYLCYSTEINE 600,0 mg | 600Effervescent tablet. | 570866.86457/10.3/0866.864Approved 18 September 2025 | Registered | S1 | PIPIL |
Regulatory status
Where S1 sits on the scale
Sold by a pharmacist, no doctor's prescription needed.
Schedule 1 medicines are normally sold by a pharmacist, or by a supervised pharmacist intern or assistant, without a doctor's visit; a veterinarian, or a licensed dispensing doctor, dentist or nurse prescriber, may also supply them. A nurse or other non-doctor prescriber may only prescribe the specific substances the Schedule names for that purpose, and may only dispense them if licensed to do so. A child under 12 may only be sold one of these medicines on a prescription, or on a written order that names the purpose and carries a signature the seller recognises.
Schedule S1, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S3; the leaflet's S1 applies to this product.
Who may supply: A pharmacist, or a supervised pharmacist intern or assistant; manufacturers and wholesalers supplying people who may lawfully possess it; a veterinarian, who may prescribe, compound or dispense it; a medical practitioner or dentist, who may prescribe it, and may compound or dispense it only if licensed under section 22C(1)(a); a nurse or other registered non-doctor prescriber, who may prescribe only the Scheduled substances the Schedule identifies for that purpose, and dispense them if licensed to do so; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Acetylcysteine
S3: Acetylcysteine
- when intended for injection or for the management of paracetamol overdosage;
- except when used as a mucolytic in acute respiratory conditions for a maximum treatment period of 14 days. (S1)
Consolidated Schedules 06 July 2026, lines 3109 to 3114
S1: Acetylcysteine
- when used as a mucolytic in acute respiratory conditions for a maximum treatment period of 14 days;
- except when intended for injection or for the management of paracetamol overdosage. (S3)
Consolidated Schedules 06 July 2026, lines 102 to 106
Pharmacological class: Others. (class 10.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2R)-2-Acetamido-3-sulfanylpropanoic acid
Drag to rotate. Structure from PubChem CID 12035.
SAHPRA documents
Schedule Verification
This medication's schedule (S1) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.